Skip to main content
Earnings Labs
MannKind Corporation logo

MannKind Corporation (MNKD)

NASDAQ·Healthcare·Biotechnology

$3.85

-1.66%

Mkt Cap $1.19B

Analyst Ratings

Buy

10

Hold

0

Sell

0

Price Target (12 analysts)

$8.50

Range $6.00$11.00

Implied Upside

+121.1%

Consensus $8.50 vs current $3.85